EN
登录

外科植入系统开发商Tenon Medical完成300万美元私募配售

WallachBeth Capital Announces Closing of Tenon Medical

CISION 等信源发布 2026-09-01 00:30

可切换为仅中文


$3M Private Placement Offering

300万美元私募发行

JERSEY CITY, N.J.

新泽西州泽西市

,

Aug. 31, 2026

2026年8月31日

/PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that Tenon Medical, Inc. (NASDAQ:

/美通社/ -- 领先的资本市场及机构执行服务提供商 WallachBeth Capital LLC 今日宣布,Tenon Medical, Inc.(纳斯达克股票代码:

TNON

TNON

) ('Tenon' or the 'Company'), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders closed its previously announced private placement pursuant to securities purchase agreement with an institutional investor to sell 597,610 shares of common stock (or pre-funded warrants in lieu thereof), together with a warrant to purchase up to an aggregate 1,058,517 shares of common stock, in a private placement offering.

Tenon(或称“公司”)是一家致力于变革某些骶骨盆疾病患者护理方式的医疗器械公司,其已根据与一家机构投资者的证券购买协议,完成此前宣布的私募配售,出售597,610股普通股(或以预付认股权证代替),并附带可认购总计最多1,058,517股普通股的认股权证。

The combined effective offering price for each share of common stock and accompanying warrants to be issued is $5.02. The combined effective offering price for each pre-funded warrant and accompanying warrants to be issued is $5.019. The pre-funded warrants will have an exercise price of $0.001 per share of common stock and the warrant will have an exercise price of $5.02 per share, will be immediately exercisable, and will expire five years from the date of issuance..

每股普通股及随附发行的认股权证的合并有效发行价格为5.02美元。每份预融资认股权证及随附发行的认股权证的合并有效发行价格为5.019美元。预融资认股权证的行权价格为每股普通股0.001美元,认股权证的行权价格为每股5.02美元,可立即行权,并自发行之日起五年后到期。

The gross proceeds to the Company from the offering are estimated to be approximately $3.0 million before deducting the placement agent's fees and other estimated offering expenses.

在扣除配售代理费用及其他预估发行费用之前,公司从本次发行中获得的总收益估计约为300万美元。

WallachBeth Capital LLC acted as the exclusive placement agent in connection with the offering.

WallachBeth Capital LLC 担任了此次发行的独家配售代理。

The offer and sale of the foregoing securities are being made in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the 'Securities Act'), and/or Regulation D promulgated thereunder, and the securities have not been registered under the Securities Act or applicable state securities laws.

上述证券的发售和销售系根据经修订的《1933年证券法》(以下简称“《证券法》”)第4(a)(2)条和/或据此颁布的D条例进行的私募配售,且该等证券未依据《证券法》或适用的州证券法律进行注册。

Accordingly, the securities may not be reoffered or resold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws. Pursuant to the terms of the securities purchase agreement, the Company has agreed to provide customary registration rights for the shares of common stock and the shares of common stock underlying the warrants and pre-funded warrants..

因此,除非依据有效的注册声明或适用《证券法》及相应州证券法律中关于注册要求的豁免规定,否则不得在美国重新要约或转售该等证券。根据证券购买协议的条款,公司已同意为普通股股份以及认股权证和预付资权证所对应的底层普通股股份提供惯常的注册权。

This press release does not constitute an offer to sell or the solicitation of an offer to buy the securities, nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state.

本新闻稿不构成出售要约或购买证券的要约邀请,也不得在根据该州证券法进行注册或资格认定之前,在任何此类要约、邀请或销售属违法的州进行证券销售。

Any offering of the securities under the resale registration statement will only be made by means of a prospectus..

依据转售注册声明进行的任何证券发售,仅可通过招股说明书进行。

About WallachBeth Capital LLC:

关于WallachBeth Capital LLC:

WallachBeth Capital offers a robust range of capital markets and investment banking services to the healthcare community, connecting corporate clients with leading institutions, supporting issuers and investors in achieving their financial goals. The firm's experience includes initial public offerings, follow-on issues, PIPE offerings, and private transactions and ATM's..

WallachBeth Capital 为医疗保健领域提供全面的资本市场和投资银行服务,将企业客户与领先机构相连接,协助发行人和投资者实现其财务目标。该公司的经验涵盖首次公开发行(IPO)、后续发行、私募股权投资PIPE、私人交易以及自动柜员机交易(ATM)。

Forward-Looking Statements

前瞻性陈述

This press release contains 'forward-looking statements,' which are statements related to events, results, activities or developments that Tenon expects, believes or anticipates will or may occur in the future. Forward-looking statements often contain words such as 'intends,' 'estimates,' 'anticipates,' 'hopes,' 'projects,' 'plans,' 'expects,' 'seek,' 'believes,' 'see,' 'should,' 'will,' 'would,' 'target,' and similar expressions and the negative versions thereof.

本新闻稿包含“前瞻性陈述”,即与Tenon预期、相信或预计将来会发生或可能发生的未来事件、结果、活动或发展相关的陈述。前瞻性陈述通常包含诸如“打算”、“估计”、“预期”、“希望”、“规划”、“计划”、“期望”、“寻求”、“相信”、“认为”、“应当”、“将”、“会”、“目标”等词语及其类似表述,以及这些词语的否定形式。

These forward-looking statements, include, but are not limited to, statements regarding the completion of the offering, the satisfaction of customary closing conditions related to the offering and the anticipated use of proceeds therefrom. Such statements are based on Tenon's experience and perception of current conditions, trends, expected future developments and other factors it believes are appropriate under the circumstances, and speak only as of the date made.

这些前瞻性陈述包括但不限于,有关完成此次发行、满足与此次发行相关的惯例交割条件以及预期募集资金用途的陈述。此类陈述基于Tenon的经验和对当前状况、趋势、预期未来发展及其他其认为在当时情况下适当因素的看法,并且仅反映作出之日的情况。

Forward-looking statements are inherently uncertain and actual results may differ materially from assumptions, estimates or expectations reflected or contained in the forward-looking statements as a result of various factors. For details on the uncertainties that may cause Tenon's actual results to be materially different than those expressed in any forward-looking statements, please review Tenon's Annual Report on Form 10-K for the fiscal year ended December 31, 2025 and updated from time to time in our Form 10-Q filings and in our other public filings on file with the SEC at .

前瞻性陈述本质上具有不确定性,由于各种因素的影响,实际结果可能与前瞻性陈述中反映或包含的假设、估计或预期存在重大差异。有关可能导致Tenon实际结果与任何前瞻性陈述中所表达的结果存在重大差异的不确定性的详细信息,请参阅Tenon截至2025年12月31日的财政年度的10-K表格年度报告,以及在我们向美国证券交易委员会(SEC)提交的10-Q表格文件和其他公开备案文件中不时更新的内容。

www.sec.gov

www.sec.gov

, particularly the information contained in the section entitled 'Risk Factors.' We undertake no obligation to publicly update or revise any forward-looking statements to reflect new information or future events or otherwise unless required by law.

,特别是“风险因素”一节中包含的信息。除非法律另有要求,我们不承担公开更新或修订任何前瞻性陈述以反映新信息或未来事件或其他情况的义务。

SOURCE WallachBeth Capital LLC

来源:WallachBeth Capital LLC

21

二十一

%

百分之

more press release views with

更多新闻稿浏览量

Request a Demo

申请演示